NM_001365276.2:c.9115+701C>G

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001365276.2(TNXB):​c.9115+701C>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.256 in 152,076 control chromosomes in the GnomAD database, including 6,404 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.26 ( 6404 hom., cov: 31)

Consequence

TNXB
NM_001365276.2 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -1.01

Publications

32 publications found
Variant links:
Genes affected
TNXB (HGNC:11976): (tenascin XB) This gene encodes a member of the tenascin family of extracellular matrix glycoproteins. The tenascins have anti-adhesive effects, as opposed to fibronectin which is adhesive. This protein is thought to function in matrix maturation during wound healing, and its deficiency has been associated with the connective tissue disorder Ehlers-Danlos syndrome. This gene localizes to the major histocompatibility complex (MHC) class III region on chromosome 6. It is one of four genes in this cluster which have been duplicated. The duplicated copy of this gene is incomplete and is a pseudogene which is transcribed but does not encode a protein. The structure of this gene is unusual in that it overlaps the CREBL1 and CYP21A2 genes at its 5' and 3' ends, respectively. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
TNXB Gene-Disease associations (from GenCC):
  • Ehlers-Danlos syndrome
    Inheritance: AR Classification: DEFINITIVE Submitted by: G2P
  • Ehlers-Danlos syndrome due to tenascin-X deficiency
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Illumina, PanelApp Australia, Orphanet
  • familial vesicoureteral reflux
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • vesicoureteral reflux 8
    Inheritance: AD Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.94).
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.368 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TNXBNM_001365276.2 linkc.9115+701C>G intron_variant Intron 26 of 43 ENST00000644971.2 NP_001352205.1
TNXBNM_001428335.1 linkc.9856+701C>G intron_variant Intron 27 of 44 NP_001415264.1
TNXBNM_019105.8 linkc.9109+701C>G intron_variant Intron 26 of 43 NP_061978.6 P22105-1O95680Q9Y464O95681

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TNXBENST00000644971.2 linkc.9115+701C>G intron_variant Intron 26 of 43 NM_001365276.2 ENSP00000496448.1 P22105-3
TNXBENST00000647633.1 linkc.9856+701C>G intron_variant Intron 27 of 44 ENSP00000497649.1 A0A3B3ISX9
TNXBENST00000375244.7 linkc.9115+701C>G intron_variant Intron 26 of 43 5 ENSP00000364393.3 P22105-3

Frequencies

GnomAD3 genomes
AF:
0.256
AC:
38968
AN:
151958
Hom.:
6396
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.0596
Gnomad AMI
AF:
0.430
Gnomad AMR
AF:
0.375
Gnomad ASJ
AF:
0.463
Gnomad EAS
AF:
0.204
Gnomad SAS
AF:
0.243
Gnomad FIN
AF:
0.400
Gnomad MID
AF:
0.339
Gnomad NFE
AF:
0.319
Gnomad OTH
AF:
0.252
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.256
AC:
38982
AN:
152076
Hom.:
6404
Cov.:
31
AF XY:
0.262
AC XY:
19486
AN XY:
74326
show subpopulations
African (AFR)
AF:
0.0595
AC:
2469
AN:
41512
American (AMR)
AF:
0.376
AC:
5745
AN:
15278
Ashkenazi Jewish (ASJ)
AF:
0.463
AC:
1607
AN:
3468
East Asian (EAS)
AF:
0.204
AC:
1055
AN:
5176
South Asian (SAS)
AF:
0.243
AC:
1171
AN:
4818
European-Finnish (FIN)
AF:
0.400
AC:
4218
AN:
10550
Middle Eastern (MID)
AF:
0.347
AC:
102
AN:
294
European-Non Finnish (NFE)
AF:
0.319
AC:
21691
AN:
67964
Other (OTH)
AF:
0.253
AC:
534
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1360
2720
4079
5439
6799
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
406
812
1218
1624
2030
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.294
Hom.:
965
Bravo
AF:
0.248
Asia WGS
AF:
0.225
AC:
784
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.94
CADD
Benign
0.68
DANN
Benign
0.57
PhyloP100
-1.0
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2857009; hg19: chr6-32019746; API